Results 241 to 250 of about 291,761 (290)
Some of the next articles are maybe not open access.

CMV

The Hearing Journal, 2013
Exclusively for TheHearingJournal.com AUGUST 2013 After two-year-old Daisy Doutre developed profound bilateral hearing loss from a common herpes virus she had at birth, her grandmother, Utah Rep. Ronda Rudd Menlove, R-Garland, took steps to raise public awareness of one of the leading causes of hearing loss in children. Rep.
openaire   +2 more sources

CMV encephalitis during ganciclovir therapy of CMV retinitis

Infection, 1990
An AIDS patient with cytomegalovirus (CMV) retinitis was treated with ganciclovir (10 mg/kg) for four days followed by 5 mg/kg for 69 days. Clinically, CMV retinitis improved during therapy. Two weeks after induction of therapy, the patient became increasingly disoriented, and died 78 days after admission.
T F, Schwarz   +5 more
openaire   +2 more sources

CMV-specific immunotherapy

Human Immunology, 2004
Considerable progress has been made in our understanding of the immunobiology of infections in immunocompromised hosts. Insights derived from animal model and human studies have provided the rationale to investigate immunotherapy with alphabeta+ T cells to restore responses considered essential for protective immunity to cytomegalovirus infection ...
Hermann, Einsele, Holger, Hebart
openaire   +2 more sources

CMV Retinitis Treatment

Optometry and Vision Science, 1995
The two drugs known to be useful in the treatment of cytomegalovirus (CMV) retinitis are ganciclovir and foscarnet--usually they are given intravenously. Intravitreal ganciclovir seems to be even more effective. A pump system to deliver the drug into the vitreous is being developed.
openaire   +2 more sources

Randomized Trial of Hyperimmune Globulin for Congenital CMV Infection — 2-Year Outcomes

New England Journal of Medicine, 2023
Brenna Hughes   +2 more
exaly  

[Cytomegalovirus (CMV)].

La Revue du praticien, 2000
Human cytomegalovirus (CMV) is an ubiquitous agent. CMV infection is a common, usually subclinical world wide infection with a tendency for virulence in congenitally-infected infants and immunosuppressed patients including allograft recipients and patients with AIDS.
openaire   +1 more source

CMV

2020
openaire   +1 more source

Home - About - Disclaimer - Privacy